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Abstract
HLA class I glycoproteins contain the functional sites that bind peptide antigens and engage
lymphocyte receptors. Recently, clinical application of sequence-based HLA typing has
uncovered an unprecedented number of novel HLA class I alleles. Here we define the nature
and extent of the variation in 3,489 HLA-A, 4,356 HLA-B and 3,111 HLA-C alleles. This anal-
ysis required development of suites of methods, having general applicability, for comparing
and analyzing large numbers of homologous sequences. At least three amino-acid substitu-
tions are present at every position in the polymorphic α1 and α2 domains of HLA-A, -B and
-C. A minority of positions have an incidence >1% for the ‘second’ most frequent nucleotide,
comprising 70 positions in HLA-A, 85 in HLA-B and 54 in HLA-C. The majority of these posi-
tions have three or four alternative nucleotides. These positions were subject to positive
selection and correspond to binding sites for peptides and receptors. Most alleles of HLA
class I (>80%) are very rare, often identified in one person or family, and they differ by point
mutation from older, more common alleles. These alleles with single nucleotide polymor-
phisms reflect the germ-line mutation rate. Their frequency predicts the human population
harbors 8–9 million HLA class I variants. The common alleles of human populations com-
prise 42 core alleles, which represent all selected polymorphism, and recombinants that
have assorted this polymorphism.
Author summary
The HLA complex is a region of the human genome containing immune system genes.
Our study concerns those HLA genes that orchestrate defense against viral infections. Dis-
tinguishing HLA genes from other human genes is their extensive variation within indi-
viduals, families and populations. One advantage of this genetic variation is to increase
the depth and breadth of the weaponry used against viruses; another is to impede the
spread of infection within families and communities. A drawback to HLA variation is that
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bone-marrow transplants between donors and patients of different HLA type trigger
immune reactions that attack and can kill the patient. For some patients an HLA identical
family member can be the donor, but for others an unrelated HLA identical donor is
sought. Facilitating these searches are registries, listing millions of possible donors whose
HLA types were determined by gene sequencing. During the last ten years, this effort pro-
duced exponential growth in the number of HLA variants sequenced. This gave us the
unprecedented opportunity to compare more than 10,000 sequences and distinguish
aspects of the variation that are important for immune functions, from those that are not.
First, however, we needed to develop software that could handle this mass of data.
Introduction
Present in all jawed vertebrates, the Major Histocompatibility Complex (MHC) is a genomic
region that encodes fundamental components of the immune system. Hallmarks of the MHC
are highly polymorphic genes that encode diverse MHC class I and II antigen-presenting mol-
ecules [1, 2]. The human MHC is called the HLA region and is present on the short arm of
chromosome 6 [3]. HLA class I and II glycoproteins have homologous structures and comple-
mentary functions in binding peptide antigens and presenting them to lymphocyte receptors
[4, 5]. HLA class II is dedicated to adaptive immunity and engagement of the αβ antigen recep-
tors of CD4 T cells [6]. In contrast, HLA class I contributes both to innate immunity, by engag-
ing Natural Killer (NK) cell receptors, and to adaptive immunity, through engagement of the
αβ antigen receptors of CD8 T cells [7]. Correlating with these functional differences, poly-
morphism within the antigen-binding site is restricted to one of the two domains that form
the site for HLA class II whereas HLA class I polymorphism is spread throughout the two
domains [8, 9]. Consequently, the number of alleles and the differences between them are
greater for HLA class I, the subject of our investigation, than HLA class II [10].
Within the HLA region, three genes, HLA-A, HLA-B and HLA-C, encode highly polymor-
phic HLA class I molecules. Sequence variation is concentrated in the α1 and α2 domains that
are encoded by exon 2 and 3, respectively. These two domains contain the binding sites for
peptide antigens and lymphocyte receptors [11]. The functional effects of the polymorphism
are first to increase the breadth of an individual’s immune response to a pathogen, and second
to diversify that response within families and populations. One clinical corollary of HLA poly-
morphism is that numerous diseases are associated with particular HLA alleles and haplotypes,
and are frequently the strongest genetic associations [7, 12]. Another clinical corollary is that
the success of allogeneic transplantation of tissues and organs improves with the extent of
HLA match between donor and recipient [13].
HLA class I typing for clinical transplantation was begun in the 1960s using low-resolution
serological methods. Nucleotide sequencing of HLA class I alleles began in the 1980s and by
1988 had led to establishment of the HLA database as the source for accurate, curated HLA
sequence data [10, 14–16]. Since that time, improvements in methods [17] have progressively
increased the discovery rate of novel alleles. By July 2016 sequences for more than 10,000
HLA-A, -B and -C alleles were deposited in the database. These alleles represent a worldwide
sampling of many, but not all, human populations. They provide a unique data set for analysis
of HLA class I variation. To analyze this variation, we developed new and general methods for
handling and analyzing these large numbers of homologous sequences. Using these tools we
examined variation in exons 2 and 3 of HLA-A, -B, and –C, which encode α1 and α2, with the
goal of identifying those aspects of HLA class I variation that have most impact on the diversity
Human major histocompatibility complex (MHC) class I diversity
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of human immune function. The methods used here to study exons 2 and 3 of HLA class I are
directly applicable to polymorphic HLA class II genes. They can also be applied to other
regions of HLA genes, which are known to harbor functionally relevant polymorphism [18–
20], when sufficient sequence data become available.
Results
The α1 and α2 domains of HLA class I glycoproteins contain the functional sites that bind pep-
tide antigens and engage lymphocyte receptors. These domains are also the site for the extraor-
dinary polymorphism of HLA class I. Clinical sequence-based typing of HLA-A, -B and -C,
targets exons 2 and 3 that encode α1 and α2, respectively. Such typing, of millions of prospec-
tive transplant donors, facilitated this analysis of sequence variation in 3,489 HLA-A, 4,356
HLA-B and 3,111 HLA-C alleles (S1 Fig).
HLA-A, -B and -C are divergent genes with diverse alleles
A general method of multi-sequence dot-plot analysis was developed (see Materials and meth-
ods) and used to compare the exon 2 and 3 sequences of HLA-A, HLA-B and HLA-C individu-
ally (Fig 1A–1C), and in combination (Fig 1D). The mean intragenic distances of the three
genes differ significantly (p<1 x 10−10, One-Way ANOVA), with HLA-C showing the shortest
average distance of 16.60 nucleotide differences (3%) compared to HLA-B, which has the larg-
est with a mean 27.65 differences between alleles (5%). HLA-A is intermediate with 22.82 dif-
ferences between alleles (4%). The average number of differences between alleles of the same
gene is 23.75, whereas the average between alleles of different genes is significantly higher at
51.12 (p<1 x 10−10, One-Way ANOVA).
The HLA-A and HLA-B dot plots show well-defined triangular clusters of closely related
alleles (Fig 1A and 1B). These clusters correspond to the HLA-A and HLA-B antigens defined
by serological typing, the method first used to define HLA class I polymorphisms [21]. Most
pairwise differences are greater than 20 nucleotides, producing an extensive white background
on which there are well-defined triangles of color. The dot-plot comparison of HLA-C alleles
also has well-defined clusters corresponding to serological HLA-C types (Fig 1C). However, in
contrast to the HLA-A and HLA-B dot plots, white areas do not dominate because HLA-C
alleles have diverged to lesser extent than HLA-A or HLA-B alleles. One likely cause of this dif-
ference is that MHC-A and MHC-B are ten million years older than MHC-C, another is that
HLA-C has distinctive functions in reproduction, which are not shared with HLA-A or -B. In
particular, HLA-C expressed on fetal trophoblast interacts with KIR on maternal uterine NK
cells to facilitate placental development [22]. Fig 1D, shows all pairwise comparisons of
HLA-A, –B and -C alleles. The color patterns show how HLA-B and HLA-C are more closely
related to each other than either is to HLA-A. The median number of differences between
sequences of HLA-B and HLA-C is 42 compared to 55–56 for differences between HLA-A and
HLA-B or HLA-C (S9 Fig). These results are consistent with MHC-C having originated with
duplication of an MHC-B allele.
All positions in the α1 and α2 domains exhibit variation
Each of the 546 positions in exons 2 and 3 can have five alternative forms, the four different
nucleotides and insertion/deletion (indel). The distribution of the variability is shown as histo-
grams in S2 Fig and the numbers per exon for each gene are given in S3 Fig. In summing the
data for the three genes, we find only 4.5% of the positions are invariant, whereas 23.2%, 34.3%
and 32.2% positions have two, three and four forms, in HLA-A, –B and –C, respectively. All
five forms are present at 5.7% of positions. The pattern of variability is similar for HLA-A, -B
Human major histocompatibility complex (MHC) class I diversity
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Fig 1. Pairwise comparison defines allele groups with high sequence similarity. The dot plots show the results of pairwise comparison of
nucleotide sequences within HLA-A, (Panel A) HLA-B (Panel B) HLA-C (Panel C) and all three combined (Panel D). A color scale indicates the
number of nucleotide differences in each pair compared with red representing the most closely related alleles. The diagonal labeling in the
individual gene plots indicates the allele groups, i.e. 01 in panel A is HLA-A*01, N indicates the number of alleles in each group that were used in
the analysis. The diagonal labels do not show the following groups where N is less than 25: A*34, A*36, A*43, A*66, A*69, A*74, A*80, B*42,
B*45, B*47, B*49, B*50, B*54, B*59, B*67, B*73, B*78, B*81, B*82, B*83 and C*18.
https://doi.org/10.1371/journal.pgen.1006862.g001
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and -C (S2 Fig). Variation was thus found at almost every position in exons 2 and 3 of these
genes.
We performed similar analysis of the amino-acid sequences of the α1 and α2 domains. The
results are displayed as histograms in S4 Fig and summarized in Table 1. The striking result is
that, for each of the three genes, there are no positions in the sequences of their protein prod-
ucts that exhibit only one or two amino acids. The number of residues at a given position var-
ies from 3 to 14, with 149 of the 181 positions having between 5 and 9 alternative amino acid
residues (Table 1).
Polymorphic positions comprise a minority of the variable positions
To distinguish positions having a balanced polymorphism between two or more nucleotides,
from positions dominated by one nucleotide, we determined the incidence (in the dataset of
allelic sequences) for the second-most common nucleotide at each position in the exon 2 and 3
sequence (Fig 2). Positions where the incidence of the second nucleotide exceeded 1% were
considered polymorphic, whereas positions with lower incidence were considered to exhibit
rare variation. The second nucleotide occurs in more than 1% of the alleles for 70 positions in
HLA-A, 85 in HLA-B and 54 in HLA-C (S5 Fig). These comprise a minority of positions in the
546 bp sequence of exon 2 and 3, demonstrating that the variation observed at most positions
in exons 2 and 3 (S2 Fig) is due to the contribution of nucleotide substitutions that are present
in one or a few alleles.
Analyzing the incidence of the second most common amino acid residue showed that all
181 positions in the α1 and α2 domains of HLA-A, -B and -C exhibit some variation. Of these
positions, however, only 45 in HLA-A, 46 in HLA-B and 32 in HLA-C have a second amino
acid incidence of>1% and are thus considered polymorphic (Fig 3, S6 Fig). Twelve of these
positions are shared by HLA-A, -B and -C: four in α1 (residues 9, 66, 77 and 80) and eight in
α2 (95, 97, 99, 114, 116, 152, 156 and 163). Larger numbers of polymorphic positions are
shared by two of the three HLA class I: 26 by HLA-A and -B, 20 by HLA-B and -C, and 14 by
HLA-A and -C. On the other hand, 17 polymorphic positions are unique to HLA-A, 12 to
HLA-B and 10 to HLA-C. These 39 positions impart considerable gene-specific character to
the polymorphism (Fig 4). This reflects functional specialization of the three HLA class I.
For polymorphic positions with a second nucleotide incidence of>1%, the mean number
of different nucleotides is 3.8 for HLA-A, 3.7 for HLA-B and 3.6 for HLA-C. The values are
higher than the mean differences for all other variable positions: 3.1 for HLA-A and HLA-B
and 2.9 for HLA-C. The polymorphic positions have a significantly increased incidence of
three or more nucleotides at each position (91%) when compared to the other positions in the
dataset (73%) (Chi squared test, p = 2.08 x 10−6). Additionally there are polymorphic positions
with three or more nucleotides with an incidence of>1%. There are nine positions in HLA-A,
14 in HLA-B and nine in HLA-C having three nucleotides with an incidence >1%. With four
nucleotides at an incidence >1% are position 527 (codon 152) in HLA-A, positions 206
(codon 45), 272 (codon 67) and 362 (codon 97) in HLA-B, and position 368 (codon 99) in
HLA-C. These results suggest that variation arising at these sites is more likely to be retained
in the population. This is consistent with the sequence variation at such sites serving to diver-
sify the functional interactions of HLA class I with peptide antigens and lymphocyte receptors.
Polymorphic positions are functional sites subject to positive selection
Crystallographic analyses have identified 70 residues in α1 and α2 domains of HLA class I that
are involved in binding peptide antigens and/or lymphocyte receptors [11, 23–27]. These func-
tionally defined residues overlap considerably with the set of polymorphic residues defined by
Human major histocompatibility complex (MHC) class I diversity
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Table 1. Every position in the α1 and α2 domains has at least three alternative amino acids.
Number of positions in domain
Distinct amino acids HLA gene α1
N = 89
α2
N = 92
α1 + α2
N = 181
1 A 0 0 0
B 0 0 0
C 0 0 0
2 A 0 0 0
B 0 0 0
C 0 0 0
3 A 3 0 3
B 0 0 0
C 3 1 4
4 A 2 1 3
B 6 1 7
C 7 6 13
5 A 14 3 17
B 11 2 13
C 14 14 28
6 A 16 13 29
B 10 12 22
C 23 22 45
7 A 29 27 56
B 25 13 38
C 19 24 43
8 A 15 20 35
B 11 18 29
C 12 12 24
9 A 7 16 23
B 10 14 24
C 6 12 18
10 A 2 5 7
B 9 12 21
C 3 1 4
11 A 1 3 4
B 2 9 11
C 1 0 1
12 A 0 3 3
B 4 5 9
C 1 0 1
13 A 0 1 1
B 1 3 4
C 0 0 0
14 A 0 0 0
B 0 3 3
C 0 0 0
https://doi.org/10.1371/journal.pgen.1006862.t001
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the incidence of the second nucleotide. Thus, 35 of 45 polymorphic HLA-A positions, 32 of 46
polymorphic HLA-B positions and 19 of 33 polymorphic HLA-C positions are functionally
important sites. This correlation of function with polymorphism is highly significant for
HLA-A (p = 6.52 x 10−7) and HLA-B (p = 1.18 x 10−6), but less so for HLA-C (p = 0.0124)
(2x2 Fisher’s Exact test). The difference is consistent with highly polymorphic HLA-A and
-B molecules interacting mainly with highly diverse αβ CD8 T cell receptors, and less polymor-
phic HLA-C molecules interacting mainly with the less diverse killer cell immunoglobulin–
like receptors (KIR) of NK cells.
The striking correlation between immunological function and genetic polymorphism was
further investigated by testing the polymorphic sites for evidence of positive selection. Our
null hypothesis was that polymorphic sites are not subject to positive selection. If correct there
would be no bias in the rates of synonymous and non-synonymous nucleotide substitutions,
as measured by the parameters dS and dN. For each test performed, the probability for reject-
ing the null hypothesis of neutral variation (dN = dS) is shown in Table 2. Values of P<0.05,
Fig 2. Frequencies of the second most common nucleotide at positions in exons 2 and 3. The histograms show the frequency
for HLA-A (top) –B (center) and –C (bottom) of the second most common nucleotide at each position in exons 2 and 3.
https://doi.org/10.1371/journal.pgen.1006862.g002
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following a Bonferroni correction and bootstrapping of 1,000 replicates, were considered sig-
nificant at the 5% level and are highlighted.
We first compared the 70 codons encoding functionally critical α1 and α2 domain residues
(Binding site codons in Table 2), as defined previously [11], to the other 112 codons of exons 2
and 3. For the 70 functional positions, the dN-dS values all point in the direction of positive
selection (3.58 for HLA-A, 2.89 for HLA-B and 2.58 for HLA-C) and are statistically significant
for HLA-A (p = 0.0031) and HLA-B (p = 0.0275) but not for HLA-C (p = 0.0720) (statistical
significance is achieved at p<0.05, after application of Bonferroni correction to the tests on a
per gene basis). In contrast, the 112 other positions (Not binding site codons) have negative
dN-dS values consistent with the null hypothesis: -1.78 for HLA-A (p = 1.0), -1.73 for HLA-B
(p = 1.0) and -1.25 for HLA-C (p = 1.0). These results argue strongly against positive selection
at the other positions.
Having validated the selection analysis on functional sites, we compared the polymorphic
codons, as defined by having at least one nucleotide position where the incidence of the second
nucleotide >1%, with the remaining codons of exons 2 and 3. For the polymorphic codons the
Fig 3. Distribution of polymorphic positions in the α1 and α2 domains. The figure shows the frequency of the second most
common amino acid at positions in the α1 and α2 domains of HLA-A (top), -B (center) and –C (bottom) allotypes where it has a
frequency >1%. Position numbering is based on the mature protein.
https://doi.org/10.1371/journal.pgen.1006862.g003
Human major histocompatibility complex (MHC) class I diversity
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Fig 4. Gene-specific positions of polymorphism. Boxes shaded black denote polymorphic positions
(where the second most common amino acid has an incidence >1%) that are only polymorphic in one of the
three HLA class I proteins.
https://doi.org/10.1371/journal.pgen.1006862.g004
Human major histocompatibility complex (MHC) class I diversity
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dN-dS values pointed clearly in the direction of positive selection and were statistically signifi-
cant: 4.98 for HLA-A (p = 0.0001), 4.55 for HLA-B (p = 0.0001) but not for HLA-C (2.20,
p = 0.1800). In contrast, the values for the codons where the second nucleotide was present at
less than 1% were all decidedly negative: -2.66 for HLA-A (p = 1.0), -3.06 for HLA-B (p = 1.0)
and -2.78 for HLA-C (p = 1.0). These data strongly support positive selection at the polymor-
phic positions.
Independent analysis of the α1 and α2 domains (Table 2) shows that dN-dS for HLA-A is
higher in α2 for both binding sites and polymorphic positions (3.342, p = 0.0067; 4.517
p = 0.0008) than α1 where selection is detected only for polymorphic positions (1.359
p = 1.0000; 3.135 p = 0.0130) which represent a subset of the functionally important residues.
For HLA-B selection was detected for the polymorphic positions in both α1 (3.467, p = 0.0044)
and α2 (2.875, p = 0.0286) and for complete set of binding site codons (2.889, p = 0.0275) but
not the individual domains. The HLA-C sequences show no significant selection differences
between the α1 and α2 domains, with neither the functional nor polymorphic positions show-
ing significant positive selection.
Assessment of selection at gene-specific positions of polymorphism (Fig 5) showed there
has been positive selection only for HLA-C specific polymorphisms and those are limited to
one of the two domains. The α1 domain has been subject to strong positive selection (dN-
Table 2. Patterns of selection vary between HLA-A, -B, and -C.
Testing the hypothesis there has been no positive selection on HLA-A, -B or -C
Exons 2 and 3 (α1+α2) Exon 2 (α1) Exon 3 (α2)
HLA Codons under test dN-dS Probability (p) dN-dS Probability (p) dN-dS Probability (p)
A All codons 1.510 0.8400 0.433 1.0000 1.652 0.6120
Binding site codons 3.576 0.0031 1.359 1.0000 3.342 0.0067
Not binding site codons -1.780 1.0000 -1.433 1.0000 -1.126 1.0000
2nd Nucleotide > 1% 4.979 0.0001 3.135 0.0130 4.517 0.0008
2nd Nucleotide not > 1% -2.661 1.0000 -1.940 1.0000 -1.638 1.0000
Gene-specific codons 0.585 1.0000 -0.522 1.0000 1.595 0.6794
Not gene-specific codons 1.150 1.0000 0.272 1.0000 0.251 1.0000
B All codons 0.408 1.0000 0.310 1.0000 0.131 1.0000
Binding site codons 2.889 0.0275 1.719 0.5280 2.362 0.1187
Not binding site codons -1.730 1.0000 -1.190 1.0000 -1.200 1.0000
2nd Nucleotide > 1% 4.552 0.0001 3.467 0.0044 2.875 0.0286
2nd Nucleotide not > 1% -3.060 1.0000 -2.360 1.0000 -1.860 1.0000
Gene-specific codons 2.444 0.0960 2.220 0.1800 2.358 0.1300
Not gene-specific codons -0.041 1.0000 -0.340 1.0000 0.270 1.0000
C All codons -0.303 1.0000 0.207 1.0000 -0.628 1.0000
Binding site codons 2.576 0.0720 1.972 0.3000 1.674 0.5760
Not binding site codons -1.251 1.0000 -1.280 1.0000 -1.227 1.0000
2nd Nucleotide > 1% 2.203 0.1800 2.161 0.2400 0.768 1.0000
2nd Nucleotide not > 1% -2.780 1.0000 -1.773 1.0000 -2.039 1.0000
Gene-specific codons 0.989 1.0000 3.653 0.0023 -0.157 1.0000
Not gene-specific codons -0.170 1.0000 -0.265 1.0000 -0.023 1.0000
Table 2 shows the results of dN-dS analysis testing for positive selection. For all tests, the probability of rejecting the hypothesis of neutral variation
(dN = dS) is shown. P-values of less than 0.05, following a correction for multiple-testing, are considered significant at the 5% level and are highlighted in
red. Corrected P-values of 0.0001 are displayed for those values output by MEGA as 0.0000 (indicating a p>0.0001). Corrected P-values exceeding 1.0000,
are shown as 1.0000.
https://doi.org/10.1371/journal.pgen.1006862.t002
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Fig 5. Gene conversion plots. The figure provides a graphical representation of the output from the algorithm used to
identify recombinant regions and plots the frequency with which each position is likely to part of a recombinant region. The two
lines represent the minimum (red) and maximum (blue) potential regions likely to have been subject to recombination. The
region with the greatest proportion of recombinants in the HLA-B graph, between positions 300 and 325, maps to the region
encoding the Bw4 motif, which is known to have recombined between different HLA-B allele groups.
https://doi.org/10.1371/journal.pgen.1006862.g005
Human major histocompatibility complex (MHC) class I diversity
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dS = 3.65, p = 0.0023), but that is not the case for HLA-C specific sites of α2 (dN-dS = -0.16,
p = 1.00). The gene-specific sites of HLA-A and HLA-B show no evidence for significant posi-
tive selection.
Distinguishing SNP and recombinant HLA class I alleles
Previous analysis of HLA class I variation, studied small numbers of alleles and relied on visual
inspection to discern the relationships between them [5]. To analyze the current dataset of
10,956 HLA class I sequences, we developed the Sq2 algorithm (see Materials and methods),
which provides a quicker, more objective and largely automated approach. In two separate
phases of analysis, Sq2 divided the alleles into three categories.
In the first phase, Sq2 identified all SNP alleles, which constitute ~85% of the dataset. These
are alleles of more recent origin that differ from an older allele by just one nucleotide substitu-
tion. After identifying and removing the SNP alleles, the reduced database of 1,555 alleles was
subjected to the second phase of analysis. This identified all alleles that are recombinants of
other alleles. To do this, Sq2 identified motifs of several substitutions that are present in multi-
ple allelic backgrounds as a consequence of recombination (Fig 5). The iconic example is the
Bw4 motif. Present in codons 76–83 of one third of HLA-B alleles, Bw4 defines the ligand rec-
ognized by a major NK cell receptor, KIR3DL1 [28, 29]. As well as being present in 12 of the
33 HLA-B allele families, Bw4 was transferred by a gene conversion from HLA-B to HLA-A,
where it spread by recombination to four HLA-A allele families [30]. By comparing the distri-
bution of such motifs among alleles, Sq2 identified pairs of alleles differing only by presence or
absence of a particular motif.
In this way 1,171 recombinants were identified. Of these 1,092 were formed by recombina-
tion between alleles of the same gene (intragenic recombinants), and 79 were recombinants
formed by recombination between alleles of different genes (intergenic recombinants). Of the
latter, 16 are products of single recombination (crossover) and 63 (10 HLA-A, 37 HLA-B, and
16 HLA-C) are products of double recombination (conversion). HLA-B is clearly seen as the
more frequent beneficiary of recombination (Table 3).
Among intragenic recombinants, double recombinants (N = 735) outnumber single recom-
binants (N = 357) by a factor of two. It is likely that some alleles assigned as single recombi-
nants are actually double recombinants, for which the second recombination is not in exon 2
or 3 but in a flanking intron, for which we had no sequence. Both forms of recombinant are
more prevalent at HLA-B (N = 728) than either HLA-A (N = 226) or HLA-C (N = 138). The
frequency of double recombination for HLA-B is similar in exons 2 and 3, whereas it is greater
in exon 2 of HLA-A and in exon 3 of HLA-C. A similar hierarchy is observed for the single
recombinants.
A set of core alleles represents all elements of HLA class I polymorphism
Removal of SNP and recombinant alleles, reduced the database to<1% of its original size.
This left 11 HLA-A, 17 HLA-B and 14 HLA-C alleles (Fig 6A). Because these 42 alleles represent
all functionally significant variation (polymorphism) in exons 2 and 3 of HLA-A, -B and -C,
we call them ‘core’ alleles (Fig 6B). Although they are older in their origins than the SNP alleles
and recombinant alleles, they are unlikely to represent, or reflect, any particular human popu-
lation, either ancient or modern.
Core alleles vary widely in their contribution to the total set of alleles (Fig 6A), in their geo-
graphical distribution (S7 Fig) and in their abundance in the modern human population. A
substantial proportion of the core alleles, 5 HLA-A, 8 HLA-B and 6 HLA-C, are likely derived
from archaic humans (Fig 6A) [31]. A dot plot analysis of the core alleles (S8 Fig) has similar
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substructure to that of the complete set of alleles (Fig 1D) and for each gene the mean pairwise
differences for core alleles and all alleles is remarkably similar (S9 Fig). Analysis of selection on
the polymorphic and functional sites of core HLA-A, -B and -C alleles (Table 4) gives compara-
ble results to those obtained for the full sets of alleles (Table 2) for HLA-A. For HLA-B and -C
the results are comparable when looking at the full-length sequence, but some differences are
seen for the individual domains. This could, however, be due to the small number of sequences
analyzed.
The effects of applying the Sq2 algorithm to the HLA class I data set are seen in histograms
constructed from the pairwise differences of nucleotide sequences (Fig 7, top row). For com-
plete sets of HLA-A, -B and -C alleles, the histograms have a characteristic bimodal distribution
with one peak at 2 nucleotide differences and a second peak at 20–30 nucleotide differences.
The first peak contains the large number of pairwise comparisons between alleles differing by
one or two nucleotide substitutions. Pairs differing by one nucleotide substitution usually
involve an older, common allele and a rare SNP variant. Pairs differing by two nucleotide sub-
stitutions involve two rare SNP variants that differ from the same parental allele by different
SNPs.
Taking the SNP alleles out of the analysis, led to loss of the first peak and retention of the
second peak (Fig 7, middle row). For HLA-A and -B the loss is complete, but for HLA-C it is
not. HLA-A gives a bimodal distribution, which differs from that observed in the complete
dataset. This is because HLA-A comprises a small number of large and divergent allele families.
Thus the minor distribution, seen as the shoulder at 4–12 nucleotide differences, comprises
the differences between members of the same allele family, whereas the major distribution is
formed from the larger differences between members of different allele families. In contrast to
HLA-A, HLA-B comprises a large number of less divergent allele families than HLA-A, as well
as a few highly divergent alleles with no close family ties. This gives HLA-B both a more sym-
metrical and broader distribution.
Histograms for the pairwise differences between core alleles (Fig 7, bottom row) represent
much of the range of difference seen with the larger data sets, with the notable absence of allele
pairs differing by small numbers of substitutions. That the HLA-C core allele histogram has a
distribution with a more coherent shape, than the HLA-A and -B core histograms, probably
reflects the more recent origin of HLA-C [4, 32].
Table 3. HLA class I alleles can be divided into three categories.
Categories of HLA class I alleles
HLA gene Number of alleles SNP alleles
Total Distinct Sequences Core alleles Recombinants Other mechanisms SNP alleles Fraction of total
sequences (%)
Intragenic Intergenic Total Distinct
A 3,489 3,170 11 226 10 127 2,796 80.1 88.2
B 4,356 4,072 17 728 47 92 3,188 73.2 78.3
C 3,111 2,872 14 138 22 123 2,575 82.8 89.7
All 10,956 10,114 42 1,092 79 342 8,559 78.1 84.6
Each allele can be assigned as a core allele, a SNP allele or a recombinant allele. The number of alleles in each of these categories is shown. Total refers to
all sequences covering exons 2 and 3 at each gene Distinct Sequences refers to the unique sequences over exons 2 and 3. Recombinants refers to alleles
formed by either Intra or Inter-genic mechanisms. Other mechanisms counts the alleles that cannot be assigned to a particular mechanisms.
https://doi.org/10.1371/journal.pgen.1006862.t003
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Fig 6. Core HLA-A, -B and –C alleles. A Starting with the 42 core alleles (11 HLA-A, 17 HLA-B and 14 HLA-C) it is possible to
derive all the other HLA-A, -B and –C alleles by events of recombination and point mutation. This is the minimum number of alleles
by which this can be achieved. The core alleles are not meant to represent any particular human population, either ancient or
modern. The yellow shading indicates potential archaic alleles that have been transmitted from Denisovans or Neanderthals. Red
shading indicates rare allele that does not have a frequency > 0.001 in more than one reference population. B An unrooted
Human major histocompatibility complex (MHC) class I diversity
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The human population is estimated to have millions of HLA class I alleles
Because we have detected variation at all nucleotide positions in exons 2 and 3 of HLA-A, -B
and -C (S2 Fig) the maximum number of possible HLA class I alleles is 5546 (4.3 x 10381). This
calculation is based on observing all four nucleotides or an indel at each of the 546 positions in
the exon 2 and 3 sequence. This number far exceeds the size of the modern human population,
which is estimated to be 7.5 billion (http://www.worldometers.info/world-population/). This
difference means that the number of variants present in a population is limited only by the size
of that population.
To estimate the total number of HLA-A, -B and -C alleles now present in the human popu-
lation, we first determined the rate at which novel alleles are being identified. In this context,
the rate is simply the ratio between the number of individuals typed and the number of new
alleles discovered. For each gene, the product of the rate and the population size (7.5 billion)
gives an estimate of the total number of alleles. To provide an internally consistent dataset, we
phylogenetic tree of the core alleles. Numbers at the nodes indicate bootstrap support. Where a number is absent, support at that
node was < 50.
https://doi.org/10.1371/journal.pgen.1006862.g006
Table 4. Patterns of selection vary between core alleles of HLA-A, -B, and -C.
Testing the hypothesis there has been no positive selection on HLA-A, -B or -C core alleles
Exons 2 and 3 (α1+α2) Exon 2 (α1) Exon 3 (α2)
HLA Codons under test dN-dS Probability (p) dN-dS Probability (p) dN-dS Probability (p)
A All codons 1.112 1.0000 -0.170 1.0000 1.825 0.4200
Binding site codons 2.421 0.0960 0.470 1.0000 2.821 0.0360
Not binding site codons -1.639 1.0000 -1.462 1.0000 -0.706 1.0000
2nd Nucleotide > 1% 6.016 0.0001 3.305 0.0041 5.102 0.0001
2nd Nucleotide not > 1% -2.936 1.0000 -2.165 1.0000 -2.129 1.0000
Gene-specific codons 1.372 1.0000 0.135 1.0000 2.670 0.0480
Not gene-specific codons 0.368 1.0000 -0.084 1.0000 0.483 1.0000
B All codons 0.250 1.0000 0.240 1.0000 0.041 1.0000
Binding site codons 2.401 0.1080 1.428 0.9360 1.577 0.7080
Not binding site codons -1.993 1.0000 -1.461 1.0000 -1.404 1.0000
2nd Nucleotide > 1% 4.023 0.0006 3.568 0.0028 1.718 0.5280
2nd Nucleotide not > 1% -3.150 1.0000 -2.697 1.0000 -1.609 1.0000
Gene-specific codons 2.905 0.0262 -0.479 1.0000 3.190 0.0130
Not gene-specific codons -0.349 1.0000 -0.468 1.0000 -0.008 1.0000
C All codons -0.100 1.0000 -0.254 1.0000 0.021 1.0000
Binding site codons 2.611 0.0600 0.733 1.0000 2.229 0.1680
Not binding site codons -2.111 1.0000 -1.803 1.0000 -1.738 1.0000
2nd Nucleotide > 1% 2.926 0.0246 2.516 0.0840 0.844 1.0000
2nd Nucleotide not > 1% -2.821 1.0000 -1.958 1.0000 -2.076 1.0000
Gene-specific codons 0.609 1.0000 5.519 0.0001 -1.713 1.0000
Not gene-specific codons -2.897 1.0000 -0.847 1.0000 0.776 1.0000
Table 4 shows the results of dN-dS analysis testing for positive selection. For all tests, the probability of rejecting the hypothesis of neutral variation
(dN = dS) is shown. P-values of less than 0.05, following a correction for multiple-testing, are considered significant at the 5% level and are highlighted in
red. Corrected P-values of 0.0001 are displayed for those values output by MEGA as 0.0000 (indicating a p>0.0001). Corrected P-values exceeding 1.0000,
are shown as 1.0000.
https://doi.org/10.1371/journal.pgen.1006862.t004
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analyzed HLA typing data from donor cohorts recruited by various transplantation registries,
but all typed at the same sequencing center (Histogenetics).
Similar rates, of 1.80, 2.13, and 2.18 x 10−4, were observed for the acquisition of novel
HLA-A, -B and –C alleles, respectively (Table 5). Using these rates, we estimate there are 2.7
million HLA-A, 3.3 million HLA-B and 3.2 million HLA-C alleles in today’s human population.
These estimates are comparable to the 3.5 million alleles per HLA gene predicted by Klitz, et al
[33], using estimates of effective population size and mutation rates.
Fig 7. Pairwise distances of alleles form characteristic distributions for HLA-A, -B and –C. Shows the distribution of pairwise
differences for all alleles (top row), core alleles and recombinant alleles (center row), and core alleles alone (bottom row) for HLA-A (left
column), HLA-B (center column) and HLA-C (right column).
https://doi.org/10.1371/journal.pgen.1006862.g007
Table 5. Rates of new allele identification.
HLA gene Number of individuals tested Number of novel alleles Frequency of novel alleles
A 3,255,436 1,177 1.80 x 10−4
B 3,260,166 1,422 2.18 x 10−4
C 3,012,398 1,284 2.13 x 10−4
On average, HLA typing ~2,000 individuals yielded one novel allele for each of the HLA class I genes three genes. Of 6,956 different HLA class I alleles
identified, 3,883 were novel alleles detected in only one individual or family.
https://doi.org/10.1371/journal.pgen.1006862.t005
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Our method for estimating the total numbers of HLA-A, -B and -C alleles used a constant
rate for the discovery of novel alleles. This assumption was based on the results of two recently
published studies [34, 35], which both indicated that the rate of discovery of new alleles is not
tapering off over time, even for European populations [34, 35], which have been intensively
studied compared to the populations of other continents.
Analyses show that the human population has a small number of common HLA class I
alleles (68 HLA-A, 125 HLA-B, 44 HLA-C) that are present at appreciable frequency in differ-
ent populations [36]. In contrast, the overwhelming majority of HLA class I alleles are very
rare and highly localized in their distribution. Consistent with these properties, each newly
sampled cohort or population is expected to harbor a subset of HLA-A, -B and -C alleles that
are novel and present in only one or a few individuals. Because of their rarity and population
specificity, the relative frequency of novel alleles will not diminish in time as further cohorts of
donor are HLA typed at high resolution.
Discussion
We studied sequence variation in exons 2 and 3 that encode the highly polymorphic α1 and α2
domains of HLA-A, -B and -C. The analysis was restricted to these exons and genes to enable
an in depth study of the maximum number of sequences. The tools developed for this analysis
can, and should, be extended to study the remaining exons of these genes, which are known to
contain functionally relevant polymorphism [18–20], when sufficient data becomes available.
These analyses can also be applied to the study of polymorphism in the HLA class II genes.
Sequence differences in the α1 and α2 domains of HLA-A, -B and -C determine the peptide
antigens that are bound by an HLA class I allotype, as well as the lymphocyte receptors that
can engage the complex of peptide and HLA class I. HLA-A, -B and -C are candidates for
being the most polymorphic of human genes [22]. Moreover, their polymorphisms are associ-
ated with numerous clinical factors including infectious diseases, autoimmune and inflamma-
tory diseases, pregnancy syndromes and success in the transplantation of allogeneic organs
and tissues [7, 37–42].
Transplantation of bone marrow, and other sources of hematopoietic stem cells, is a suc-
cessful and widely used therapy for leukemias, lymphomas and other malignancies of hemato-
poietic cells. The preferred donor is an HLA identical sibling, but in the absence of such a
donor, the next best choice is an unrelated individual having the same, or very similar, HLA
type as the patient. To identify such donors, there exists an international network of donor reg-
istries, which has HLA typed more than 30 million potential HCT donors [43]. During the last
ten years, less precise methods of HLA typing have been superseded by nucleotide sequencing
exons 2 and 3 of the HLA-A, –B and –C genes.
The set of HLA class I sequences we studied derive from sequence-based typing of>3 mil-
lion individuals, as well as earlier studies in which typing at lower levels of resolution identified
variants, which were followed up with targeted sequence analysis. The prospective donors of
hematopoietic stem cells were recruited to registries in varied countries and continents, but
demographically and anthropologically they are not, in the main, well characterized. A total of
10,956 different exon 2 and 3 sequences were analyzed: 3,489 HLA-A, 4,356 HLA-B and 3,111
HLA-C alleles. In our analysis of these three sets of alleles, each sequence was given equal
weight, irrespective of its abundance or scarcity in any human population.
At the nucleotide level, we found substitutions at>95% of all positions in each of the three
genes. As the exceptions are at different positions in each gene, we predict that substitution at
these positions will soon be identified. At the amino-acid level, we found substitutions at every
position in the α1 and α2 domains of HLA-A, -B and –C. A majority of the substitutions,
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>84%, are in rare alleles, which in many cases have been detected in only one individual or
one family. Most of the alleles differ from a common allele by the single substitution that
defines them. The obvious interpretation of these data is that these substitutions reflect the
germ line mutation rate of the HLA-A, –B and –C genes. Consistent with this thesis, there is no
evidence for positive selection at these sites, many of which are, otherwise, highly conserved.
The remaining alleles are formed by intragenic or, rarely, intergenic recombination events.
From the rate at which new alleles in exons 2 and 3 have been defined by sequence-based typ-
ing we estimate there are 2–3 million each of HLA-A, -B and -C alleles in the human popula-
tion worldwide.
The majority of the variable nucleotide positions are characterized by one dominant and
one or more rare nucleotides. However, variation at a smaller number of nucleotide positions,
(70, 85 and 54 in HLA-A, -B and -C, respectively) has a very different character. These posi-
tions have two, three or four nucleotides at appreciable frequency. They have also been spread
by recombination throughout the population of alleles and are thus found in numerous combi-
nations. There is good evidence for positive selection at these sites, which has over time, given
them a balanced polymorphism. Supporting this conclusion, numerous immunological studies
have correlated substitution at polymorphic sites with modulation of HLA-A, -B and –C func-
tion [7, 37, 40, 41, 44–46]. Thus we can divide the alleles into two distinctive groups. Firstly
SNP alleles, defined by substitution that confers no functional benefit, but could be detrimen-
tal in the context of transplantation. Secondly, functional alleles, with functional benefit con-
ferred by combinations of substitutions at positions with balanced polymorphism.
We further divided the functional alleles into two subgroups: 1,171 recombinant alleles that
were derived by recombination from other alleles and 42 core alleles (11 HLA-A, 17 HLA-B
and 14 HLA-C) that cannot be derived by simple events of recombination from other alleles.
The core alleles, many of which were passed by introgression from archaic to modern humans
[31], contain all elements of HLA-A, -B and –C polymorphism present in the modern human
population. Although the core alleles are probably older than the SNP alleles and the recombi-
nant alleles, they are very unlikely to represent the HLA-A, -B and -C alleles carried by any par-
ticular ancestral human population.
Because polymorphic MHC class I and II genes have no wild-type, understanding their
genetics and biology in any species requires extensive study of populations. For reasons of cost
and logistics this has been rarely, if ever, achieved. Many population studies have recruited
only small numbers of individuals (therefore, likely missing rare alleles) and until recently
have reliably assayed only known alleles. Because the HLA class I and II genes contribute to so
many numerous and diverse aspects of human health and disease [7, 37–42], the MHC of the
human species is by far the most studied and, by default, provides the model for studies of
other placental mammals [4, 32, 47–49]. The capacity to acquire large datasets, of the type we
have analyzed and reported here, should enable HLA population genetics and disease associa-
tions to be studied to increasingly higher definition, resolution and coverage of the world’s
human populations.
Materials and methods
The HLA class I sequence dataset
The minimum requirement for naming an HLA class I allele and depositing it in the
IPD-IMGT/HLA Database, is the nucleotide sequence of exons 2 and 3. Because of this
requirement, a majority of deposited sequences (~65% of HLA-A and -B alleles and ~80% of
HLA-C alleles) consist of only exons 2 and 3, encoding residues 2-182 of the mature HLA class
I protein. Thus to maximize the number of alleles analyzed we limited this study to the
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sequences of exons 2 and 3. Our analysis used all sequences in the IPD-IMGT/HLA database
as of July 2016 (Release 3.25.0).
Methods of sequence comparison and analysis
All analyses used custom written Perl scripts, http://www.perl.org [50], with graphical outputs
generated using the Perl::GD modules or R, http://www.r-project.org [51]. Where appropriate,
statistical analysis was also completed in R. For F distribution analyses with df1 and df2
exceeding 1,000, R outputs a p-value of 0, these have been reported as p<1 x 10−10. The set of
scripts developed constitutes the Sq2 package. Individual scripts perform different steps of the
algorithm. The individual algorithms are listed and described below:
1. sq2_basealigner.pl—prepares the sequence for alignment, utilizes ClustalW and then for-
mats the alignment for use in further scripts.
2. sq2_msdotplot.pl—generates the multiple sequence dot plots
3. sq2_histovariant.pl—is used to measure the diversity at each position and plot the values as
a histogram
4. sq2_identifyf2.pl—is used to identify polymorphic positions, where the second allele is at a
set frequency
5. sq2_removemono.pl—is a perl module used to remove invariant positions from sequence-
alignment libraries
6. sq2_v3.pl—this perl script has options to identify SNP and recombinant variants
7. sq2_recombiner.pl—this perl script identifies the recombinant regions between groups of
sequences.
The scripts are available from the ANHIG Gitlab repository which can be found at; https://
github.com/ANHIG.
Sequence alignment—sq2_basealigner.pl. For each of the three genes the combined exon
2 and 3 sequences of all alleles were aligned using the ClustalW alignment tool [52]. The out-
put was processed using sq2_basealignmer.pl, which removed redundant sequences and
recoded insertions and deletions so as to preserve the alignment. Redundant sequences arise
because some alleles differ only by non-coding region substitutions, or coding region substitu-
tions outside of exons 2 and 3. The script, sq2_basealigner.pl, removes all but one of a set of
repeated sequences. The retained sequence is that with the lowest number in the allelic series.
In recoding an insertion, the sequence of the insertion and the preceding nucleotide were both
replaced by the letter ‘I’ for indel. In recoding a deletion, each one of the deleted nucleotides
was represented in the sequence by the letter ‘I’.
To shorten computation times and give clarity when viewing the output of analyses, the
sq2_removemono.pl was developed to remove invariant positions from sequence alignments.
Depending on the gene, between 7–14 positions in exon 2 and 11–16 positions in exon 3 were
removed from the alignments.
Dot plot comparison of HLA class I sequences—sq2_msdotplot.pl. Dot plots have been
widely used to compare pairs of sequences [53]. In expanding this concept, we developed a
multiple sequence dot plot method (sq2_msdotplot.pl) that compares any number of sequences
in a single plot. Dot plots were made from the exon 2 and 3 sequences of HLA-A, HLA-B
and HLA-C alleles, separately, as well as in combination. In these plots, compared sequences
are listed along both the x and y axes. Each pairwise comparison is represented by a colored
dot on a two dimensional plot. The color of the dot indicates the similarity of the sequences:
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red indicating identity, proceeding through orange, yellow, green, and blue to white as the
similarity decreases. A characteristic diagonal red line is produced by all comparisons of a
sequence with itself.
Histograms of sequence variation—sq2_histovariant.pl. The script, sq2_histovariant.pl,
was developed to take aligned HLA-A, -B and -C sequences and generate histograms for the
number of different nucleotides, as well as insertion-deletion (I) that occur at each position.
Amino-acid sequence variation of HLA-A, -B and -C allotypes was similarly analyzed using
sq2_histovariant.pl.
The initial set of histograms determined which nucleotides occur at each position, but gave
no measure of their relative frequencies in the allele population. To provide this measure, we
developed the sq2_identifyf2.pl script that constructs a second set of histograms giving the fre-
quency of the second most common nucleotide at each position.
Using Sq2 to segregate mutant, recombinant and core HLA-A, -B and -C
alleles
Alleles of an HLA class I gene are of three types: core alleles, recombinant alleles and SNP
alleles. Core alleles comprise the set of alleles that cannot be related to each other by single
events of recombination or point mutation. Recombinant alleles are the products of one or
more recombination events between core alleles. SNP alleles differ from another allele by a sin-
gle nucleotide polymorphism (SNP). The Sq2 algorithm was developed to assign HLA class I
alleles to these three categories. In a series of iterative steps, Sq2 first defines the mutant alleles,
then the recombinant alleles and lastly the core alleles.
Identification of mutant alleles—sq2_v3.pl. For all pairs of alleles, the Sq2 algorithm
determines the minimum number of substitutions that is needed to convert one allele to the
other. This is achieved by calculating the hamming distance (HamD) a measure developed in
the field of information theory [54]. Two alleles with a HamD of 1 differ by a single nucleotide
substitution. Sq2 identifies chains, clusters and networks of allele that are connected by steps
of one substitution. Each connected set of alleles forms a single event group (SEG), an example
being the cluster of 453 HLA-A02 alleles that each differ from HLA-A02:01:01:01by one
nucleotide substitution (Fig 8).
In pairs of alleles that differ by one nucleotide substitution, one allele (the parent) is ances-
tral and the other (the child) is derived. Having defined all possible allele pairs with a HamD of
1, the algorithm initially gives equivalent consideration that each member of the pair is the par-
ent. The number of child alleles for each candidate parent is usually very different, so the algo-
rithm then assigns the allele with the most children as the parent. For the A02:01:01:01 SEG it
is obvious, because A02:01:01:01has 423 potential children, very few of which have any poten-
tial children apart from A02:01:01:01. Assignment of the parent can lead to additional alleles
being incorporated into the SEG. Initially, A02:35:01was assigned its own SEG, because it dif-
fers from HLA-A02:01:01:01 by two nucleotide substitutions and has 5 child alleles. There are
two child alleles that are a single SNP from both the HLA-A02:11:01 and HLA-A02:01:01:01
SEGs. The HLA-A02:35:01 group can be absorbed into either of these larger groups and in
this case HLA-A02:01:01:01 SEG is used, as it contains the most children. The analysis also
revealed closed circular connections between several alleles, a consequence of different muta-
tions occurring at the same nucleotide position (Fig 8).
A large majority of HLA-A, -B and -C alleles are SNP alleles. To identify recombinant and
core alleles, the SNP alleles were first removed from the sequence alignments.
Identification of recombinant alleles and core alleles—sq2_v3.pl. The RDP2 [55] and
TOPALi [56, 57] methods that are much used for identifying recombination events are based
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Fig 8. Most alleles within a SEG are related by single point substitutions. Shows all of the members of the final
HLA-A*02:01:01:01 SEG. A The parental HLA-A*02:01:01:01 allele has 423 “child” alleles that vary from
A*02:01:01:01 by a point substitution (green). Additional alleles can be connected by two or more point substitutions
(red). In the algorithm the intermediate SEGs, for example HLA-A*02:07:01, are constructed and subsequently
added to other larger SEGs. B Ten other HLA-A*02 SEGs were identified that could not directly be linked to the
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on mathematical models [58, 59] that assume recombination is infrequent. For HLA class I
alleles that is not the case, particularly for our reduced dataset that is enriched for recombinant
alleles. In testing the capacity of RDP2 and TOPALi to identify recombinant HLA class I alleles,
we found these programs only identified a subset of the recombinants, and these were ones
that were obvious from visual inspection.
To improve the detection of recombinants within the reduced HLA class I dataset we devel-
oped another algorithm that relies on pattern matching. This part of Sq2 uses HamD to iden-
tify the most similar alleles, and the motifs that distinguish them. The algorithm treats the gain
or loss of sequence motifs as single events, and generates Motif Event Groups (MEGs) based
upon the analysis of these events. For example, exchange of the Bw4 for the Bw6 motif [28, 60]
at nucleotide positions 310–320 in HLA-B is considered a single event. HLA-B alleles differing
only by Bw4/Bw6 are placed in the same MEG. The output of the analysis is a series of MEGs,
for which the size and content is compared and parent alleles selected. These MEG parents are
candidate core alleles.
This methodology is repeated in an iterative manner, comparing alleles in the data set and
the motifs generated. This permitted further reduction of the database as two or more alleles
were assigned to a MEG. Where possible this was done programmatically, providing an initial
reduced set of alleles. Visual inspection was then performed to facilitate identification of more
complicated patterns of recombination. To aid this analysis, invariant positions in the
sequence were removed from alignments. The alignments were based on the consensus
sequence and the alleles ordered by their increasing deviation from the consensus. No alleles
having a unique nucleotide substitution were removed from the dataset. For some MEGs,
determination of the core allele could not be achieved programmatically. In those cases, the
global distributions of the candidate alleles were compared and the most widely distributed
allele chosen as the MEG progenitor. After removing SNP and recombinant alleles, the data-
base was reduced to a set of 42 core alleles: 11 HLA-A, 17 HLA-B and 14 HLA-C.
Identification of core alleles enabled us to refine the characterization, definition and assign-
ment of recombinant motifs using a computational algorithm. Starting at the 50end of exon 2,
each core allele was compared to the allele under study for identity at each nucleotide position.
When a difference was detected the comparison was stopped. For all core alleles, these regions
of identity were compared and the longest one selected. The process was then started again
from the position following the 30end of the first identity region, and was continued through
to the 30end of exon 3. This produced a profile of regions with identity to the core alleles. The
process was then repeated, but was started at the 30end of exon 3 and then proceeded to the
50end of exon 2. The two profiles were then combined to produce a map of potential recombi-
nant regions, which highlighted the maximum and minimum areas needed for recombination.
The algorithm was also seeded with both core alleles and known recombinants, which allowed
the identification of second or third generation recombinants. The algorithm was also used to
identify intergenic and intragenic recombination events.
Targeted dN-dS analysis of positive selection
The MEGA software package, version 5.1, [61–63] was used to assess positive selection in
HLA-A -B, and -C sequences using the codon-based Z-test of selection. The analysis used the
HLA-A*02:01:01:01 SEG because they differed from it by more than one point substitution and no intermediate
alleles were identified. All of the SEGS with more than a single child are derived by intragenic recombination. Six of
the seven are based on an intragenic recombinant involving the HLA-A*02:01:01:01 SEG. The seventh is the core
allele HLA-A*02:05:01.
https://doi.org/10.1371/journal.pgen.1006862.g008
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Kumar method [64], with variance of the difference being computed by the bootstrap method
(1,000 replicates, to allow for multiple testing). For each gene dN and dS analysis examined the
exon 2 and 3 sequences, both separately and combined. Further to this, analysis was performed
on specific codons. In these experiments, the nucleotide positions of interest were extracted
from each allele and an artificial sequence created. All allele sequences were then compiled
into a single data file that could be run through the dN-dS analysis. Each of these data sets was
analysed for the positions across the combined exon 2 and 3 sequence, as well as for the posi-
tions within the individual exons. In all cases, the probability of rejecting the null hypothesis of
strict-neutrality (dN = dS) in favor of the alternative hypothesis (dN>dS) is shown in Tables 2
and 4. P-values were subject to Bonferroni correction for multiple comparison. P-values of less
than 0.05 are considered significant at the 5% level and are highlighted.
Phylogenetic tree construction
Full-length coding sequences of the core alleles were obtained from the IPD-IMGT/HLA Data-
base. Sequences were aligned in Geneious 7 [65] using the MAFFT algorithm [66]. The align-
ment was input into MEGA 7 and the tree was constructed using the Neighbor Joining
method with pairwise deletion, the Tamura-Nei model, and 1000 bootstrap replicates. It is dis-
played as an unrooted tree in Fig 6B [67, 68] and bootstrap values of>50 are shown on the
tree.
Maps of allele frequency in human populations
For the core alleles, maps of their frequency distribution in human populations were generated
using ArcGis 10 [69]. Population allele frequencies and location coordinates were downloaded
from allelefrequencies.net [70]. Only anthropologically well-characterized populations of>50
individuals were included. Specifically excluded were admixed populations, populations of
recent migrants, bone marrow registry populations and the subjects of disease association
studies. Populations with low resolution HLA class I typing, (less than two field, four digit res-
olution) were not included in the final dataset.
Supporting information
S1 Fig. The rate of data acquisition increased with improvements in clinical HLA typing.
Shown are the numbers of HLA-A [blue], HLA-B [red], and HLA-C [green] sequences depos-
ited in the IPD-IMGT/HLA Database at various times between 1988 and 2016. The slope of
each curve gives the rate of data acquisition. The colored bars just above the x-axis denote time
periods when different methods of clinical HLA typing were dominant. Green; a period when
serological HLA typing dominated and techniques to clone and sequence HLA alleles were
first developed. This gave sequences for the common alleles. Purple; DNA based methods for
typing HLA class I alleles were developed and applied. Most of these techniques were based
upon sets of oligonucleotide probes. These methods had limited potential to detect ‘new’
alleles. Grey; the period in which high resolution probe-based typing was developed and first
applied to typing the large panels of donors needed for bone marrow transplantation. These
methods had improved potential to detect ‘new’ alleles Orange; high resolution high-volume
sequence-based typing is introduced and begins to be applied to the millions of donors in the
bone marrow transplant registries. These methods detect every ‘new’ allele.
(TIF)
S2 Fig. Nucleotide diversity plots. The plots show the number of different nucleotides (A, C,
G, T, indel) seen at each position. Numbering of positions is per the full-length mRNA
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sequence. Bars extending below the baseline indicate conserved positions with only a single
nucleotide present in all alleles.
(TIF)
S3 Fig. Most positions in α1 and α2 have more than one possible nucleotide. Each position
can have a maximum of five different nucleotides with the fifth nucleotide being an insertion
or deletion. This shows the number of positions in each category.
(TIF)
S4 Fig. Amino acid diversity plots. The plots show the number of amino acid residues found
at each position. The numbering is the position in the mature protein. Similar to S2 Fig, con-
served residues would be shown as bars extending below the baseline. There were no con-
served residues in any of the genes (Table 1).
(TIF)
S5 Fig. Polymophic positions: Where the second nucleotide has a frequency >1%. Shown
for HLA-A, HLA-B and HLA-C are all positions in exons 2 and 3 where the second most com-
mon nucleotide has a frequency >1%. The table shows the frequency of the first and second
most common nucleotides. The final column shows all of the nucleotides seen at the position
in descending order of frequency.
(TIF)
S6 Fig. Polymorphic positions: Where second amino acid has a frequency >1%. Shown for
HLA-A, HLA-B and HLA-C are all positions in the sequence of the α1 and α2 domains where
the second most common amino acid has a frequency >1%. The table shows the frequency of
the first and second most common amino acids. Highlighted yellow are residues that contrib-
ute to the antigen recognition site.
(TIF)
S7 Fig. Maps showing the distributions of HLA core alleles in human populations. Allele
frequencies and location coordinates were downloaded from allelefequencies.net. Only popu-
lations of greater than 50 individuals, and for which samples were collected for anthropologic
studies, were included in the analysis.
(PDF)
S8 Fig. Pairwise comparison of the nucleotide sequences of HLA class I core alleles. The
dot plots show the results of pairwise comparison of the nucleotide sequences of the core alleles
(Fig 6). A color scale indicates the number of nucleotide differences in each pair compared
with red representing the most closely related alleles. The grid shows the values for the pair-
wise differences within each gene for the complete set of alleles and the core alleles.
(TIF)
S9 Fig. Statistics for all pairwise differences. The upper panel shows the values for the pair-
wise distance calculations displayed in Fig 7. Entries are the numbers of calculations performed.
Values are shown for all gene calculations indicated by A, B, or C, intra-group (within SEGs),
inter-group (between SEGs), and cores. In addition, comparison between pairs of genes, all
intra-gene and all inter-gene is also shown. The lower panel provides the values for the distance
of individual comparison from the mean value for each of the groupings. For example, in the
line for the HLA-A gene (A) the minimum distance from the mean value is 0.18, representing
23 differences, the maximum distance is 34.18, representing the maximum value of 57 differ-
ences, and the remaining values describe the average distances from the mean.
(TIF)
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